Consumers of Certain Generic Medications in America Could Benefit from Settlement Payments

Connecticut Attorney General's Office Announces Settlement for Generic Drug Purchasers

The Connecticut Attorney General's office has recently announced a new settlement agreement that may benefit consumers who purchased specific generic medications in the U.S., claiming that some manufacturers artificially inflated prices. This current settlement involves Glenmark Pharmaceuticals, Inc., USA, which is one of the defendants in ongoing litigation.

In this case, a coalition of state attorneys general has filed lawsuits citing illegal collusion among various manufacturers to manipulate the prices of multiple generic prescription drugs sold in America. Consumers, including individuals purchasing prescriptions, may have paid inflated costs directly due to the actions of these manufacturers. Importantly, the litigation does not question the safety or efficacy of the medications involved.

Who is Eligible for the Settlement?

To qualify for the settlement, consumers must meet the following criteria:
1. You must have purchased generic prescription medication produced by any of the defendants.
2. The medication must be among those specifically involved in the litigation.
3. The purchase must have occurred between May 1, 2009, and December 31, 2019.
4. You must reside in one of the participating states or territories, including Washington D.C.

A comprehensive list of the medications involved and the full eligibility requirements can be accessed at AGGenericDrugs.com or through the consumer hotline at 1-866-290-0182.